As the transcription factors SREBP1 and SREBP2 are master regulators of several lipogenic enzymes involved in both fatty acid and cholesterol synthesis, targeting them offers a strategy that simultaneously addresses multiple components of lipid metabolism in PCa. The gene discussed is SREBF1; the disease is posterior cortical atrophy.